Published in Adv Enzyme Regul on January 01, 1989
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul (1984) 35.22
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med (2000) 7.48
Biologically active carbazole alkaloids from Murraya koenigii. J Agric Food Chem (1999) 4.43
The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci (2001) 4.33
Fos expression in orexin neurons varies with behavioral state. J Neurosci (2001) 3.08
Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Eur J Biochem (1981) 3.01
Melanopsin in cells of origin of the retinohypothalamic tract. Nat Neurosci (2001) 2.79
BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. Antimicrob Agents Chemother (1991) 2.66
Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science (1987) 2.51
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. Antimicrob Agents Chemother (1987) 2.47
Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J Theor Biol (1976) 2.42
A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem (1977) 2.32
Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J Virol (2001) 2.30
Isolation and characterization of a novel insecticidal crystal protein gene from Bacillus thuringiensis subsp. aizawai. J Bacteriol (1991) 1.94
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod (1999) 1.94
Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro. J Infect Dis (1991) 1.93
Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120. AIDS Res Hum Retroviruses (1992) 1.85
Unusual electrocardiographic manifestation of pulmonary embolism. Am Heart J (1970) 1.74
Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci (2001) 1.62
Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst (1998) 1.60
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon. Antimicrob Agents Chemother (1986) 1.51
The binding of colchicine by sarcoma 180 cells. Biochem Pharmacol (1968) 1.43
A method of estimating curare-like activity on the isolated phrenic nerve diaphragm preparation of the rat. Br J Pharmacol Chemother (1947) 1.42
Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch Biochem Biophys (2000) 1.42
THIOUREA AS A KEY REAGENT FOR THE PREPARATION OF ALIPHATIC SULPHONYL CHLORIDES AND BROMIDES. Science (1936) 1.41
Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100. J Acquir Immune Defic Syndr (2000) 1.41
Design of antineoplastic agents on the basis of the "2-phenylnaphthalene-type" structural pattern. 2. Synthesis and biological activity studies of benzo]b]naphtho[2,3-d]furan-6,11-dione derivatives. J Med Chem (1993) 1.41
Characterization of two genes encoding Bacillus thuringiensis insecticidal crystal proteins toxic to Coleoptera species. Appl Environ Microbiol (1992) 1.40
Are platelet cytosolic free calcium, serotonin concentration and blood viscosity different between hypertensive and normotensive subjects? Cardiology (1994) 1.40
Unexpected cardiac arrest in patients after surgical correction of tetralogy of Fallot. Circulation (1975) 1.40
Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys (1998) 1.38
Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine (2001) 1.37
Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother (1992) 1.36
Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol (1976) 1.35
Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr (1997) 1.35
Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine (2000) 1.35
Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med (1998) 1.33
Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. Proc Natl Acad Sci U S A (1999) 1.33
Neonatal binge ethanol exposure using intubation: timing and dose effects on place learning. Neurotoxicol Teratol (1997) 1.32
Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res (1999) 1.31
Novel bioactivities of Curcuma longa constituents. J Nat Prod (1998) 1.30
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. J Hum Virol (2001) 1.28
Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis. Antimicrob Agents Chemother (1986) 1.28
Unreliability of conventional electrocardiographic monitoring for arrhythmia detection in coronary care units. Am J Cardiol (1973) 1.28
Irinotecan is an active agent in untreated patients with metastatic colorectal cancer. J Clin Oncol (1996) 1.27
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins. AIDS Res Hum Retroviruses (1997) 1.26
Lamivudine or stavudine in two- and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. J Infect Dis (1996) 1.26
Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A. J Infect Dis (1990) 1.25
Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro. Antimicrob Agents Chemother (1992) 1.25
Incorporation of metabolites of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues. Biochem Pharmacol (1982) 1.24
Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol (2001) 1.17
Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res (1996) 1.17
Pressure sores and paraplegia: an experimental model. Ann Plast Surg (1985) 1.17
Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation (1991) 1.13
Polygammaglutamyl metabolites of methotrexate. Biochem Biophys Res Commun (1973) 1.12
Electrocardiographic diagnosis of right ventricular infarction. Am J Med (1981) 1.09
Effects of adenosine on gabaergic synaptic inputs to identified ventrolateral preoptic neurons. Neuroscience (2003) 1.09
Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine. Cancer Res (1983) 1.09
Experimental focal segmental glomerulosclerosis in mice. Nephron (1998) 1.08
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem (1998) 1.08
Metabolism of daidzein and genistein by intestinal bacteria. J Nat Prod (1995) 1.07
Changes in microbial contamination levels of porcine carcasses and fresh pork in slaughterhouses, processing lines, retail outlets, and local markets by commercial distribution. Res Vet Sci (2012) 1.06
Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation. Cancer Res (1998) 1.06
Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity. Cancer Res (1993) 1.06
A rapid assay procedure for ATP:L-methionine adenosyltransferase. Biochim Biophys Acta (1972) 1.05
Synergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother (1989) 1.05
Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine (2000) 1.03
The identification of poly-gamma-glutamyl chain lengths in bacterial folates. Biochemistry (1974) 1.03
Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication. Antimicrob Agents Chemother (1996) 1.03
Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure. J Acquir Immune Defic Syndr (1990) 1.02
Bioactive N-isobutylamides from the flower buds of Spilanthes acmella. Phytochemistry (1999) 1.02
Degradation products of cyanidin glycosides from tart cherries and their bioactivities. J Agric Food Chem (2001) 1.02
Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats. Cancer Res (1981) 1.01
Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine. Antimicrob Agents Chemother (1991) 1.01
Metabolism of 1-beta-D-arabinofuranosylcytosine in human leukemic cells. Cancer Res (1977) 1.00
Novel antioxidant compounds from tart cherries (Prunus cerasus). J Nat Prod (1999) 1.00
Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies. Cancer Res (1999) 1.00
Two novel strains of Bacillus thuringiensis toxic to coleopterans. Appl Environ Microbiol (1991) 0.99
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine. J Infect Dis (1989) 0.99
Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis (1998) 0.99
Antioxidant polyphenols from tart cherries (Prunus cerasus). J Agric Food Chem (1999) 0.98
GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry. J Neurosci (2001) 0.97
Atenolol in hypertension a study of long-term therapy. Postgrad Med J (1977) 0.97
In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic. Antimicrob Agents Chemother (1990) 0.96
Passive immunization against oral AIDS virus transmission: an approach to prevent mother-to-infant HIV-1 transmission? J Med Primatol (2001) 0.95
Insecticidal toxins from Bacillus thuringiensis subsp. kenyae: gene cloning and characterization and comparison with B. thuringiensis subsp. kurstaki CryIA(c) toxins. Appl Environ Microbiol (1991) 0.95
Trimethoprim and sulphamethoxazole in the treatment of chronic chest infections. Chemotherapy (1969) 0.95
Insights into long-range structural effects on the stereochemistry of aldol condensations: a practical total synthesis of desoxyepothilone F. J Am Chem Soc (2001) 0.95
The mechanism of S-adenosyl-L-methionine synthesis by purified preparations of bakers' yeast. Biochemistry (1972) 0.95
Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma. Cancer Gene Ther (2001) 0.95
Utilization of stomach content DNA to determine diet diversity in piscivorous fishes. J Fish Biol (2011) 0.93
Response to exercise in patients after total surgical correction of Tetralogy of Fallot. Circulation (1976) 0.93
Alternating versus continuous drug regimens in combination chemotherapy of human immunodeficiency virus type 1 infection in vitro. Antimicrob Agents Chemother (1994) 0.93
Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro. J Infect Dis (1997) 0.93
Rational approach to the clinical protocol design for drug combinations: a review. Acta Paediatr Taiwan (2001) 0.93
Management of atrial flutter after the Fontan procedure. J Am Coll Cardiol (1994) 0.93
In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors. Antimicrob Agents Chemother (1990) 0.92